|Day Low/High||136.35 / 137.81|
|52 Wk Low/High||74.32 / 138.88|
THRX CDW RHI are going ex-dividend tomorrow, Friday, November 21, 2014
CDW (NASDAQ: CDW), a leading provider of technology solutions to business, government, education and healthcare, today announced a new collaboration with the cloud-based software service Canvas to broaden the offering...
Stocks with insider trader activity include PX, CDW and BMY
Actions Reinforce Refreshed Capital Allocation Priorities
When students returned for the new school year they were greeted by smiling teachers, new lesson plans and No.
CDW (NASDAQ:CDW), a leading provider of technology solutions to business, government, education and healthcare, will launch the next iteration of its "People Who Get IT" integrated brand campaign on Oct.
Investors in CDW Corp saw new options begin trading this week, for the November 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CDW options chain for the new November 22nd contracts and identified the following put contract of particular interest.
Stocks with insider trader activity include CDW, ATRO and BMS
TheStreet highlights 3 stocks pushing the Computer Software & Services industry lower today.
Trade-Ideas LLC identified CDW (CDW) as a new lifetime high candidate
FSIC CDW RHI are going ex-dividend tomorrow, Thursday, August 21, 2014
Reinforces Commitment to Delivering Value to Shareholders
Upgrades: ADVS, AMID, CSRE, CVGI, DFRG, DNKN, ERIC, HCCI, IPCM Downgrades: AGNC, ANCB, LBY, MRIN, TGE, TPX, TREX Initiations: CDW, HDS, SAMG Read on to get TheStreet Quant Ratings' detailed report:
CDW (NASDAQ: CDW), a leading provider of technology solutions to business, government, education and healthcare, today announced its sponsorship of two PGA TOUR® champions, Gary Woodland and Camilo Villegas.
CDW Corp (CDW) stock has had its price target and estimates increased, Barclays said Thursday. The firm said the revision was driven by demand in healthcare and SMB with higher levels of solution sales. A $36 price target has been set and "overweight" rating reiterated.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.